C Burg

492 total citations
35 papers, 389 citations indexed

About

C Burg is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, C Burg has authored 35 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 12 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in C Burg's work include Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and RNA Interference and Gene Delivery (5 papers). C Burg is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and RNA Interference and Gene Delivery (5 papers). C Burg collaborates with scholars based in France, United States and Sweden. C Burg's co-authors include Jacques Le Pendu, D Sabolović, M Wioland, Antoine Ménoret, D. Oth, Khaled Méflah, Jean‐Yves Douillard, Arthur Kay, Pascale Perrin and N.R. Cutler and has published in prestigious journals such as Nature, The Journal of Immunology and Gastroenterology.

In The Last Decade

C Burg

34 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Burg France 9 194 162 49 36 36 35 389
Ann Mary United States 11 163 0.8× 92 0.6× 52 1.1× 28 0.8× 23 0.6× 19 449
H.G. Opitz Germany 12 124 0.6× 300 1.9× 59 1.2× 78 2.2× 10 0.3× 18 454
Root Rk United States 7 172 0.9× 126 0.8× 43 0.9× 14 0.4× 105 2.9× 9 408
Miyoko Takahashi Canada 12 315 1.6× 65 0.4× 30 0.6× 72 2.0× 40 1.1× 19 553
Torunn Løvdal Norway 8 183 0.9× 121 0.7× 34 0.7× 69 1.9× 106 2.9× 8 459
N Flint United Kingdom 9 346 1.8× 68 0.4× 82 1.7× 35 1.0× 138 3.8× 12 495
Charnell I. Sommers United States 13 108 0.6× 66 0.4× 70 1.4× 90 2.5× 26 0.7× 15 360
H S Koren United States 13 144 0.7× 351 2.2× 80 1.6× 47 1.3× 21 0.6× 18 550
Anne Marmenout Belgium 7 292 1.5× 298 1.8× 58 1.2× 77 2.1× 20 0.6× 8 569
Thomas M. Luby United States 10 136 0.7× 216 1.3× 65 1.3× 17 0.5× 13 0.4× 12 350

Countries citing papers authored by C Burg

Since Specialization
Citations

This map shows the geographic impact of C Burg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Burg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Burg more than expected).

Fields of papers citing papers by C Burg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Burg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Burg. The network helps show where C Burg may publish in the future.

Co-authorship network of co-authors of C Burg

This figure shows the co-authorship network connecting the top 25 collaborators of C Burg. A scholar is included among the top collaborators of C Burg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Burg. C Burg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagner, Paul D., C Burg, Maria Bradley, et al.. (2025). The Translational Dermatology Initiative: Aiming at a New Disease Classification of Inflammatory Skin Diseases. JID Innovations. 5(5). 100381–100381.
2.
Burg, C, et al.. (1998). Effects of stress on amino acids and related compounds in various tissues of fasted rats. Life Sciences. 63(16). 1485–1491. 15 indexed citations
3.
Ménoret, Antoine, et al.. (1995). Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas. The Journal of Immunology. 155(2). 740–747. 76 indexed citations
4.
Burg, C, Jacques Le Pendu, Marie‐France Moreau, et al.. (1995). Leukaemia Inhibitory Factor derived from rat colon carcinoma cells increases host susceptibility to tumour growth. Cytokine. 7(8). 784–792. 4 indexed citations
5.
Perrin, Pascale, E. Cassagnau, C Burg, et al.. (1994). An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis. Gastroenterology. 107(6). 1697–1708. 59 indexed citations
6.
Blottière, Hervé M., C Burg, Rahima Zennadi, et al.. (1992). Involvement of histo‐blood‐group antigens in the susceptibility of colon carcinoma cells to natural killer‐mediated cytotoxicity. International Journal of Cancer. 52(4). 609–618. 22 indexed citations
7.
Blottière, Hervé M., Rahima Zennadi, C Burg, et al.. (1992). Relationship between sensitivity to natural killer cells and MHC class‐I antigen expression in colon carcinoma cell lines. International Journal of Cancer. 50(4). 659–664. 8 indexed citations
8.
Blottière, Hervé M., Antoine Ménoret, C Burg, Jean-Yves Douillard, & Jacques Le Pendu. (1992). Identification and characterization of a rat protein (P 105) auto‐antigenic in rats bearing a progressive syngeneic colon carcinoma. International Journal of Cancer. 50(2). 315–320. 1 indexed citations
9.
Douillard, Jean‐Yves, Jorge Laborda, C Burg, et al.. (1989). Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors.. PubMed. 49(3). 687–92. 19 indexed citations
10.
Burg, C, et al.. (1972). Genetic dependence of the quantitative release of a cytotoxic soluble factor from mixed culture of murine splenic cells.. The Mouseion at the JAXlibrary (Jackson Laboratory). 2 indexed citations
11.
Donner, M., et al.. (1972). Release of a cytotoxic factor by murine spleen cells in the presence of a tumour allograft. Cellular and Molecular Life Sciences. 28(11). 1352–1353. 2 indexed citations
12.
Donner, M., et al.. (1972). Analyse quantitative in vivodes réctions immunitaires dirigées contre les antigénes associés a des tumeurs murines solides. International Journal of Cancer. 9(1). 30–38. 3 indexed citations
13.
Donner, M., et al.. (1972). Factors influencing the effect of an adjuvant on the growth of solid isogeneic tumors. European Journal of Cancer (1965). 8(2). 141–147. 3 indexed citations
14.
Oth, D., M. Donner, & C Burg. (1971). Measurement of the antitumoral immune reactions against a strain-specific chemically-induced sarcoma in syngeneic and F1 hybrid mice. European Journal of Cancer (1965). 7(5). 479–482. 8 indexed citations
15.
Donner, M., et al.. (1971). Release of a non-specific cytotoxic factor by splenic cells immunized against allogeneic tumour cells.. PubMed. 16(3). 240–3. 2 indexed citations
16.
Sabolović, D, D. Oth, & C Burg. (1971). Immunological reactivity to sheep red blood cells in three congenic resistant strains of mice.. PubMed. 20(3). 341–4. 8 indexed citations
17.
Oth, D., et al.. (1969). Anomalies de la courbe dose reponse d'animaux syngeniques a l'inocula- tion d'un petit nombre de cellules tumorales.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1 indexed citations
18.
Donner, M., et al.. (1969). Simultaneous decrease of tumor-specific antigenicity and "hybrid effect" in a murine methylcholanthrene-induced sarcoma.. PubMed. 8(5). 742–5. 2 indexed citations
19.
Donner, M., et al.. (1967). [Effect of BCG on immunization induced by an isologous tumor in its originial strain and in F1 hybrids].. PubMed. 161(7). 1661–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026